U.S. Diabetic Neuropathy Market to Witness Stunning Growth with Eli Lilly & Company, Johnson & Johnson Services, Pfizer
BURLINGAME, CA, UNITED STATES, February 20, 2025 /EINPresswire.com/ -- The global U.S. Diabetic Neuropathy Market is expected to grow at 5.2% CAGR from 2025 to 2032. The latest Research report published by CMI with the title "An Increase in …